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Abstract
The interaction of a 19 amino acid vesicular stomatitis virus G protein fragment (GTWLNPGFPPQSCGYATVT) with
phosphatidylserine-containing model membranes was investigated using solution-phase 1d and 2d 1H NMR spectroscopy
and intrinsic tryptophan fluorescence. Results of these studies show that this peptide interacts with model membranes
containing negatively charged phospholipids. The interaction is modulated by both ionic and hydrophobic factors and
appears to be dependent on the fluidity and lipid packing of the target bilayer. The data further suggest the existence of two
isomeric forms of this peptide, which react differentially with model membranes. Upon binding, 2d 1H NOESY and
tryptophan fluorescence data indicate penetration of the tryptophan residue into the bilayer. A model is proposed for the
interaction of the peptide with model membranes, consistent with the experimental findings. ß 1998 Elsevier Science B.V.
All rights reserved.
Keywords: Vesicular stomatitis virus G protein; Phosphatidylserine; Model membrane; Nuclear magnetic resonance; Fluorescence
1. Introduction
The detailed molecular mechanisms by which ve-
sicular stomatitis virus (VSV) binds and fuses with
host cells remain elusive. Speci¢c cellular receptors
for VSV have been postulated to be various anionic
plasma membrane lipidic components, including
phosphatidylserine (PS), phosphatidylinositol (PI),
and the ganglioside GM3 [1^3]. It has also been pro-
posed that binding of VSV does not occur via spe-
ci¢c cellular receptors but is mediated by non-speci¢c
electrostatic interactions [4]. A complete molecular
model of the fusion of VSV with cellular plasma
membranes is also lacking. However, certain funda-
mental properties are known, namely that fusion, as
well as binding, of VSV is mediated by the viral G
protein [5]. Furthermore, VSV fusion is low pH-de-
pendent with a threshold activation of pH 6.3 [6]. It
is reported that the fusion event depends on lipid
mobility and packing in the target membrane, but,
unlike binding, is not modulated electrostatically
[7,8].
In more recent reports, a 19 amino acid epitope in
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the VSV G protein was shown to be important in cell
entry of VSV [9,10]. This epitope, GTWLNPGF-
PPQSCGYATVT (called the VSV 19-mer hence-
forth), is located between residues 118 and 136 of
the G protein and is conserved among native VSV
serotypes [11]. To determine the integral importance
of this epitope in the fusion process, a mutant VSV
was generated with a new site of glycosylation at
residue 117, which masks this epitope sterically [9].
This mutant is identical to the wild-type virus in
terms of viral assembly and G protein folding; how-
ever, it is unable to fuse with host cells [9]. Thus, it is
postulated that this epitope may play a direct role in
the entry processes of VSV.
Since the VSV G protein 19-mer may directly in-
teract with target membranes during the binding and
fusion processes, and these processes have been re-
ported to be modulated by plasma membrane lipid
species, model studies of the interactions of the VSV
19-mer peptide with model membranes were under-
taken. Previous studies have successfully used solu-
tion-phase nuclear magnetic resonance (NMR) spec-
troscopy to provide molecular details concerning
small peptide/model membrane interactions [12^14].
In this contribution, NMR spectroscopy and intrin-
sic tryptophan £uorescence are used to provide struc-
tural and conformational information concerning the
interactions of the VSV 19-mer peptide with model
membranes.
2. Materials and methods
2.1. NMR studies
2.1.1. Bu¡er
All NMR studies were performed in 5P7.4 bu¡er
(5 mM Na2DPO4 (Wilmad), D2O, pH 7.4) unless
otherwise stated. The pH of 5P7.4 was adjusted
with NaOD or DCl, and no correction was made
for the isotope e¡ect. 5P7.4 bu¡er was degassed
and saturated with argon before use.
2.1.2. Synthesis of VSV G protein 19-mer
The VSV 19-mer (MW 2000) was synthesized by
the PAN Facility, Beckman Center, Stanford Univer-
sity Medical School. VSV 19-mer was puri¢ed by
reverse-phase high performance liquid chromatogra-
phy (HPLC) with a linear gradient of acetonitrile
(10^40% (v/v)) with an elution time of 40 min. The
HPLC pro¢le revealed two closely spaced peaks with
a peak area ratio of 72:28, with the larger peak elut-
ing ¢rst (Fig. 1). However, analysis by capillary elec-
trophoresis revealed only one component, indicative
of stable conformers of the same primary sequence in
the HPLC analysis (A. Sanchez, personal communi-
cation). Purity (s 95%) was further supported by
amino acid analysis. The dual peaks observed in
HPLC analysis are consistent with a prior report of
resolvable cis/trans isomers of some peptides around
proline-proline bonds at room temperature ([15]; see
Section 4). Aqueous solutions of VSV 19-mer con-
tained 10 mol% dithiothreitol (DTT) to protect the
cysteine residue. The VSV 19-mer was stored with
desiccant as a white powder at 320‡C.
2.1.3. Preparation of small unilamellar vesicles
(SUVs)
Pure phospholipid (Avanti Polar Lipid) and phos-
pholipid mixtures were solubilized in 13X100 test
tubes with chloroform and a few drops of methanol.
The solvent was removed by a gentle stream of ar-
gon. The resulting oily residue was dried in vacuo for
at least 4 h before use. Lipid mixtures were resus-
pended in 5P7.4, and layered with argon. Tubes were
covered with Para¢lm, then aluminum foil, and so-
nicated in a bath sonicator. Sonication temperature
was kept at approx. 25‡C by periodic addition of ice,
except for dioleoylphosphatidylcholine (DOPC):dio-
leoylphosphatidylserine (DOPS) (1:1) SUVs, which
were generated at approx. 5‡C. Sonication was al-
lowed to proceed to clarity, which varied from 15
min for dimyristoylphosphatidylcholine (DMPC):di-
myristoylphosphatidylserine (DMPS) (1:1) SUVs to
2^3 h for pure DMPC SUVs. Upon complete soni-
cation, the vesicles were adjusted to the appropriate
pH with NaOD or DCl. Before use, sonicated SUVs
were allowed to incubate at 37‡C for 10^15 min to
establish thermal equilibrium.
2.1.4. Sample preparation, data collection, and
analysis
SUVs were added to VSV 19-mer (and any other
additives) in 5P7.4 in 528PP NMR tubes (Wilmad)
and mixed by hand-shaking. This order of addition
was necessary as aggregation events were often evi-
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dent if VSV 19-mer were added to SUVs. NMR
samples had a total volume of 500 Wl. An external
co-axial 1H NMR chemical shift reference tube (Wil-
mad) containing 1 mM sodium 3-trimethylsilylpropi-
onate-2,2,3,3-d4 (TSP) in 5P7.4 was inserted into the
sample volume. The NMR samples were incubated
for 10 min at the temperature of interest before spec-
tral acquisition.
NMR spectra were accumulated on a General
Electric GN-500 NMR spectrometer equipped with
a 293 pulse programmer, variable temperature, and a
Sun Microsystems Sun 3 data system. 1d and 2d
NMR data were processed with Felix 2.30 software
(Biosym Technologies, San Diego, CA) on a Silicon
Graphics Iris Indigo Elan Workstation (Silicon
Graphics, Mountain View, CA). During 1d process-
ing, free induction decays (FIDs) were multiplied by
exponential functions to increase apparent signal-to-
noise with concomitant linewidth broadening (0.5
Hz). Standard 1d 1H NMR spectra were acquired
at 500 MHz with the basic pd-Z/2-t2 pulse sequence,
without presaturation of HOD, and a delay time (pd)
of 2 s. The number of scans was empirically deter-
mined for each sample so that good signal-to-noise
was achieved.
2d 1H phase-sensitive double-quantum ¢ltered ho-
monuclear COSY spectra were acquired with the
standard pulse sequence pd-Z/2-t1-Z/2-t2, with four-
step phase-cycling during both Z/2 pulses. Pulse delay
(pd) was 1 s, and two dummy scans were accumu-
lated before the actual scan was recorded. 512 t1
increments were collected to yield 256 hypercomplex
points. Each increment consisted of 2K data points
and was the average of 32 scans. The sweep width in
each dimension was near 5000 Hz. Residual HOD
was suppressed by low-level rf presaturation during
the time between acquisitions and before the obser-
vation pulse. The t1 data were collected in alternate
block mode to suppress t1 noise. COSY spectra were
processed with apodization by a 60‡ phase-shifted
squared sine bell function before Fourier transforma-
tion. A ¢fth-order polynomial baseline correction
was applied to both dimensions. The data were
zero ¢lled such that the ¢nal data matrix was
2KU2K points.
2d 1H phase-sensitive NOESY spectra were ac-
Fig. 1. Reverse-phase HPLC analysis of puri¢ed VSV 19-mer. The column was eluted with a linear gradient of 10^40% (v/v) acetoni-
trile in H2O for 40 min at ambient temperature. Eluent was assayed for peptide (OD 280). The ratio of peak areas is 72:28.
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quired similarly, using the pulse sequence Z/2-t1-tm-Z/
2-t2, where tm is the mixing period. Other parameters
of collection and analysis followed as stated above
for COSY spectra.
2.2. Tryptophan £uorescence studies
Samples were prepared by addition of 10 mM
DMPC, DMPC:DMPS (1:1), or DMPS SUVs in
5P7.4 to a VSV 19-mer concentrate in 5P7.4 in
quartz £uorescence cuvettes at ambient temperature.
The ¢nal volume of £uorescence samples was 2 ml.
The ¢nal concentration of peptide in all cases was
100 WM. SUVs were added to VSV 19-mer in the
following lipid:peptide ratios: 0:1, 1:1, 5:1, 12.5:1,
and 25:1. Samples were incubated for 10 min at am-
bient temperature with occasional mixing by hand.
Tryptophan £uorescence emission spectra were gen-
erated on a Perkin-Elmer LS50B Luminescence Spec-
trometer. Slit widths of both excitation (Vexc 280 nm)
and emission (Vem scanned from 335 to 365 nm) were
set at 10 nm with 1% attenuation. Fluorescence data
were processed using FLWinlab 1.10 software (Per-
kin-Elmer, Foster City, CA). Vmax was reported as
the Vem of greatest intensity. vVmax is de¢ned as the
di¡erence between Vmax of peptide alone and Vmax at
a speci¢c lipid:peptide ratio. A positive vVmax indi-
cates a blue shift in Vmax. Fluorescence intensity was
reported as the ratio F/F0, where F is the intensity of
£uorescence in arbitrary units at Vmax and at a given
lipid:19-mer ratio. F0 is the control £uorescence in-
tensity of peptide alone.
Fig. 2. The aromatic region of the 1H NMR spectra of VSV 19-mer (2 mM) in 5P7.4, 37‡C. Final concentrations of DMPC:DMPS
(1:1) SUVs: a, 0 mM lipid; b, 12.5 mM lipid; c, 25 mM lipid; d, 50 mM lipid. Vertical lines indicate assigned resonances in the free
peptide spectrum (trace a) given in Table 1.
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3. Results
3.1. Characterization of the aromatic region of the
1H NMR spectrum of VSV 19-mer
The aromatic region of the 1H NMR spectrum of
puri¢ed VSV 19-mer is shown in Fig. 2 (trace a). The
peptide contains three aromatic residues: W-3 near
the amino terminus, F-8 in the middle of the peptide,
and Y-15 near the carboxy terminus. Other residues
were not characterized in these studies since their
up¢eld 1H NMR resonances are completely obscured
by overlapping resonances arising from phospholipid
upon addition of model membranes to the peptide.
Attempts were made to rectify this situation using
perdeuterated phospholipids in order to mask lipid
1H NMR signals, but the degree of deuteration was
insu⁄cient to reduce the undesired lipid signals to
tolerable levels. The assigned aromatic residues, how-
ever, report uniquely on three di¡erent regions of the
peptide sequence. The aromatic resonance assign-
ments are shown in Fig. 2, and chemical shifts are
tabulated in Table 1. The resonance assignments are
derived from the 1H homonuclear COSY spectrum
of this region (Fig. 3). Generally, the most deshielded
aromatic resonances arise from the tryptophan resi-
due, and the most shielded resonances arise from
tyrosine. The phenylalanine peaks appear in the
crowded central part of the aromatic region, and
no attempt was made to make individual peak as-
signments for this residue. The chemical shifts of the
tryptophan and tyrosine resonances correspond
closely to reported values for these residues in ran-
dom-coil proteins [16]. The well-resolved tyrosine
2H,6H and 3H,5H and tryptophan 4H and 7H res-
onances show small degrees of asymmetry. For ex-
ample, the tyrosine 3H,5H resonance (N 6.84 ppm) at
37‡C shows two lower intensity shoulders superim-
posed on the main doublet at very slightly more
shielded values (Fig. 2, trace a). These asymmetric
resonances most likely represent populations of these
residues which are in slightly di¡erent electronic en-
vironments (see Section 4).
3.2. DMPC:DMPS (1:1) SUVs cause resonance line
broadening and chemical shift changes in the
aromatic region of the 1H NMR spectrum of
VSV 19-mer
Aromatic peptide resonances change signi¢cantly
when DMPC:DMPS (1:1) SUVs are added to VSV
19-mer (Fig. 2). With increasing lipid concentration,
the peptide resonance linewidths generally broaden,
indicative of peptide/SUV binding. Some chemical
shift di¡erences also are evident. The tryptophan
and phenylalanine resonances between 7.1 and 7.7
ppm experience general changes in chemical shift.
Four protons of the tryptophan sidechain shift up-
Table 1
Resonance assignments of the aromatic region of the 1H NMR
spectrum of VSV 19-mer in 5P7.4, 37‡C
Protona N (ppm)
W 4H 7.65 (doublet)
W 5H 7.17 (triplet)
W 6H 7.26
W 7H 7.50 (doublet)
Y 2H,6H 7.11 (doublet)
Y 3H,5H 6.84 (doublet)
F 2H-6Hb 7.25^7.40
aProtons are identi¢ed according to numbering system above.
bAssignments were not made for individual phenylalanine pro-
tons.
Table 2
1H NMR chemical shift di¡erences of VSV 19-mer (2 mM) aro-
matic resonances upon addition of DMPC:DMPS (1:1) SUVs
(25 mM total lipid) in 5P7.4, 37‡C
Proton N ppm (free) N ppm (bound) vN ppm
Trp 4H 7.65 7.62 0.03
Trp 7H 7.50 7.48 0.02
Trp 6H 7.27 7.21 0.06
Trp 5H 7.18 7.13 0.05
Tyr 2H,6Ha 7.11 7.11 0.00
Tyr 3H,5Ha 6.84 6.84 0.00
aNew resonances appear at very slightly more shielded values
upon addition of SUVs, changing the apparent splitting pattern
of these resonances from doublets to triplets (see Section 4).
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¢eld, as shown in Table 2 for a lipid:peptide ratio of
12.5:1. Chemical shift di¡erences which are not read-
ily apparent from the 1d spectrum are determined
from intraresidue crosspeaks in the NOESY (d 150
ms) spectrum (data not shown). At this ratio of lipid
to 19-mer, tryptophan 6H experiences the most sig-
ni¢cant shielding, with a chemical shift di¡erence of
0.06 ppm. The resonances of the tyrosine residue do
not exhibit similar chemical shift di¡erences. How-
ever, the asymmetry seen in these resonances in the
free peptide becomes more pronounced with increas-
ing lipid concentration. The up¢eld shoulders of the
free peptide tyrosine resonances shift further up¢eld
in the presence of PC:PS SUVs, such that these
peaks are now resolved from the main doublets
and appear as triplet patterns (Fig. 2, traces c,d).
Therefore, a population of tyrosine residues experi-
ences a change in electronic environment upon inter-
action with PC:PS SUVs while another apparently
does not.
3.3. Reduced vesicle charge inhibits changes in the
aromatic region of the 1H NMR spectrum of
VSV 19-mer
The e¡ect of neutralizing the SUV surface negative
charge and the resulting changes to the VSV 19-mer
1H NMR aromatic region are shown in Fig. 4. At
pH 7.4, with pure DMPC vesicles and with
DMPC:DMPS (1:1) SUVs in 150 mM NaCl
(shielded SUV surface charge), the aromatic resonan-
ces are not signi¢cantly di¡erent from those in the
spectrum of free peptide. A negatively charged SUV
surface and, therefore, electrostatic interaction are
necessary for association between VSV 19-mer and
SUVs.
Fig. 3. The aromatic region of the phase-sensitive 1H homonuclear COSY spectrum of VSV 19-mer (6.7 mM) in 5P7.4, 37‡C. The sca-
lar connectivities are shown by arrows. Notation along diagonal refers to protons assigned in Table 1.
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3.4. Changes in the 1H NMR aromatic region of VSV
19-mer are dependent on PS concentration and
SUV structure
When VSV 19-mer is incubated with 100% DMPS
SUVs, line broadening and increased shielding are
greater than for peptide incubated with
DMPC:DMPS (1:1) SUVs at the same total lipid
concentration (Fig. 5, traces a,b). However, when
19-mer is incubated with pure DMPS or
DMPC:DMPS (1:1) SUVs containing the same PS
concentration, the changes in the NMR spectrum are
more signi¢cant for the lipid mixture (Fig. 5, traces
b,c). For example, in the pure DMPS/peptide sam-
ple, the chemical shift di¡erence of the tryptophan
5H resonance is approx. 0.08 ppm. The correspond-
ing di¡erence for mixed PC:PS SUVs with the same
overall PS:peptide concentration is 0.13 ppm.
When VSV 19-mer is incubated with DOPC:
DOPS (1:1) SUVs (Fig. 5, trace d), which contain
unsaturated acyl chain lipids, the peptide resonances
are broadened more than with DMPC:DMPS (1:1)
SUVs containing the same overall lipid concentration
(Fig. 5). Chemical shift changes are generally greater
as well ; for example, the tryptophan 5H and 6H
resonances shift further up¢eld.
3.5. Changes in the 1H NMR aromatic region of VSV
19-mer are not PS-speci¢c
When DMPS is replaced with dimyristoylphospha-
tidylglycerol (DMPG), another saturated phospho-
lipid that has an overall charge of 31 at pH 7.4,
the changes induced in the aromatic region of the
1H NMR spectrum of the VSV 19-mer are identical
to those induced by PS (data not shown). Therefore,
Fig. 4. The role of e¡ective SUV surface charge on the 19-mer 1H NMR aromatic region (2 mM peptide; 25 mM total lipid; 37‡C).
a, 19-mer only, 5P7.4; b, 19-mer+DMPC:DMPS (1:1) SUVs, 5P7.4+150 mM NaCl; c, 19-mer+DMPC SUVs, 5P7.4.
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the changes are not headgroup speci¢c as long as an
overall negative charge is present.
3.6. DMPC:DMPS (1:1) vesicle/19-mer mixtures
exhibit protein-protein and protein-lipid 1H
homonuclear nOe crosspeaks
2d 1H NOESY experiments on free VSV 19-mer at
several mixing times (50, 150, and 200 ms) show no
evidence of nOe crosspeaks (data not shown) due to
fast motion [17] and nulled nOe intensities under
these conditions (w0dcV1) [13]. However, when the
19-mer is added to PS-containing SUVs, the peptide
experiences motional immobilization and di¡erences
in electronic environments at speci¢c residues, as
shown in the 1d NMR studies. Thus, the 19-mer
may adopt a preferred conformational structure
upon interaction with SUVs. Indeed, apparent pep-
tide-peptide and peptide-lipid nOe crosspeaks appear
in the NOESY (d 150 ms) spectrum of 19-mer in the
presence of DMPC:DMPS (1:1) SUVs. Cross-sec-
tional 1d slices through two aromatic resonances
are shown in Fig. 6. A slice through the tryptophan
4H resonance (Fig. 6a), shows a signi¢cant crosspeak
with a resonance at 3.26 ppm. This resonance most
likely corresponds to the choline methyl group of
DMPC. The crosspeak at 4.27 ppm is also most
likely due to a lipid resonance, probably the DMPS
serine methylene. There are three other signi¢cant
crosspeaks, one at 1.37 ppm and a doublet at 0.85
and 0.80 ppm. These resonances are not present in
the lipid spectrum, so they probably re£ect peptide-
Fig. 5. The e¡ect of SUV structure on the 19-mer 1H NMR aromatic region (2 mM peptide), 5P7.4, 37‡C. a, 19-mer+DMPC:DMPS
(1:1) SUVs (25 mM total lipid); b, 19-mer+DMPS SUVs (25 mM total lipid); c, 19-mer+DMPC:DMPS (1:1) SUVs (50 mM total
lipid) ; d, 19-mer+DOPC:DOPS (1:1) SUVs (25 mM total lipid).
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peptide nOe crosspeaks. The 0.85 and 0.8 ppm reso-
nances are the most shielded resonances of the pep-
tide and can be assigned to the non-equivalent meth-
yl groups of leucine [16], which is the residue
immediately following tryptophan. The second NO-
ESY 1d slice, through the tyrosine 2H,6H resonance
(Fig. 6b), shows fewer crosspeaks than that through
the tryptophan 4H. The only two signi¢cant cross-
peaks for this resonance occur at 3.09 and 2.95 ppm.
These most likely arise from intraresidue relaxation
with the neighboring L-methylene protons of tyrosine
itself, since they do not appear when the 1d slice
through the tyrosine 3H,5H diagonal peak is exam-
ined (data not shown). The appearance of nOe cross-
peaks between the tryptophan sidechain and both
lipid and other peptide protons indicate a more di-
rect and stronger interaction of this residue with the
SUV bilayer, in contrast with the tyrosine residue,
where lipid and interresidue nOe crosspeaks are ab-
sent.
3.7. PS changes the intrinsic tryptophan £uorescence
spectrum of VSV 19-mer
The interaction of the VSV 19-mer was further
examined by intrinsic tryptophan £uorescence.
Changes to the tryptophan £uorescence emission
spectrum of the 19-mer are indicative of interactions
of the peptide amino terminus region (H2N-GTWL)
with PS-containing SUVs. Both Vmax and the inten-
sity at Vmax (F/F0) of tryptophan £uorescence emis-
sion are a¡ected by PS (Fig. 7). When 19-mer is
incubated with PS-containing SUVs with increasing
lipid:peptide ratios, a decrease in Vmax (i.e., an in-
crease in vVmax ) and an increase in F/F0 is observed.
Tryptophan emission blue shifts and increases in
quantum yield (F/F0) are indicative of movement of
the tryptophan from a polar to a more non-polar
environment, e.g., penetration of the tryptophan
into the SUV bilayer [18]. These changes are not
observed with DMPC SUVs. Furthermore, the
changes to tryptophan £uorescence emission are dif-
ferential with respect to SUV composition, with the
mixed DMPC:DMPS SUVs showing greater interac-
tion with the 19-mer tryptophan region compared to
pure PS SUVs. Changes to Vmax are slightly greater
for PC:PS SUVs compared to pure PS SUVs at the
same lipid concentration (Fig. 7a). However, at the
same PS concentration, the changes to Vmax are sig-
ni¢cantly greater for the PC:PS SUVs. Di¡erential
interaction of 19-mer with PC:PS and PS SUVs is
most evident in changes to F/F0 (Fig. 7b). At the
same lipid concentration, £uorescence intensity of
the peptide is enhanced in the presence of PC:PS
SUVs compared to pure PS SUVs. At the same PS
concentration, this di¡erence is substantially greater.
4. Discussion
Mechanistic details of the binding and fusion of
VSV with host cells remain largely a mystery. The
cell receptor for VSV has been postulated to be PS,
among other lipid species [1^3,19]. For the native G
protein mediated fusion process, in vivo studies have
shown fusion to be dependent on low pH [6], mem-
brane £uidity and lipid packing [7,8], and inclusion
of cholesterol in the target membrane [8]. The re-
quirement for PS as a co-factor for actual fusion
has yet to be demonstrated.
A conserved epitope of the VSV G protein is pro-
posed to be necessary for entry of VSV into target
cells [9,10]. This epitope, denoted the VSV 19-mer,
has the primary sequence GTWLNPGFPPQSCGY-
ATVT. Solution-phase NMR and £uorescence stud-
ies of this peptide were undertaken to explore its
interaction with PS-containing SUVs.
Fig. 6. The up¢eld regions of 1d slices through aromatic VSV
19-mer 1H NMR resonances of the NOESY spectrum (d 150
ms) of peptide (6.7 mM)+DMPC:DMPS (1:1) SUVs (84 mM
total lipid). a, tryptophan 4H; b, tyrosine 2H,6H.
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HPLC of the synthesized 19-mer suggests that
there are two stable isomers of the peptide at room
temperature, the less prevalent isomer being slightly
more hydrophobic. This is consistent with reports
that stable cis/trans isomers exist around proline-pro-
line bonds in some peptides [15,20]. The cis isomers
are further stabilized by the interaction of aromatic
sidechains with the ¢rst proline ring [20]. The major,
more soluble, trans species is most likely in a more
extended conformation, while the less soluble cis
component is more folded and compact in this re-
gion. 1d 1H NMR also suggests this isomerism as
Fig. 7. The e¡ect of SUV concentration and composition (8, DMPC; F, DMPS; R, DMPC:DMPS) on the intrinsic £uorescence
emission spectrum of VSV 19-mer. a, change in maximum emission wavelength (vVmax); b, F/F0. SUVs were added to VSV 19-mer in
5P7.4 to give solutions containing 100 WM peptide and lipid concentrations as indicated in the ¢gure. Error bars re£ect the standard
deviation of ¢ve replicate measurements.
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indicated by the asymmetry (shoulders) in the tryp-
tophan and tyrosine resonances of the free peptide
(Fig. 2). Thus, this internal structural feature around
the restricted proline-proline bond may impart small
but detectable structural di¡erences at the trypto-
phan and tyrosine residues between the two peptide
isomers.
Fig. 8 sketches a model for the interaction of the
VSV 19-mer with SUVs, consistent with a synthesis
of the experimental ¢ndings. When DMPC:DMPS
(1:1) SUVs are incubated with the 19-mer, the pep-
tide experiences 1H NMR general linewidth broad-
ening and chemical shift di¡erences at particular res-
idues, indicative of 19-mer/SUV binding. Binding is
further substantiated by changes to the 19-mer tryp-
tophan £uorescence emission spectrum. An approx-
imate binding constant (Ka) using tryptophan 4H
proton chemical shift di¡erences was calculated to
be 63 M31, using the equation of Deber and Behnam
[21]. This value may be an overestimation since the
chemical shift for completely bound peptide was not
determined (N at very high lipid:peptide ratios), and
the chemical shift of the tryptophan resonance at the
highest lipid:peptide ratio (50:1) examined was sub-
stituted in its place. Even so, this Ka is comparable to
other binding constants of peptides that have been
shown to interact with SUV model membranes (K-
factor/DOPC/PS: [13]; enkephalin/DOPC: Deber
and Behnam [21]).
Although the peptide interaction is not speci¢c for
PS, the vesicle must contain phospholipids carrying
negative charge. No interaction is observed with
pure DMPC SUVs. An important driving force is
therefore the electrostatic interaction of the 19-mer
amino terminus with the negative bilayer. The neces-
sity of this electrostatic factor was substantiated by
the absence of interaction at higher ionic strengths.
It is interesting to note that in the intact VSV G
protein, the 19-mer sequence is immediately pre-
ceded by a lysine residue, thus mimicking the charge
characteristics of the amino terminus of the free pep-
tide.
Upon electrostatic direction of the VSV 19-mer to
the PC:PS SUV via the amino terminus, other fac-
tors augment the binding. A hydrophobic e¡ect is
seen in the tryptophan region next to the amino ter-
Fig. 8. Proposed model of VSV 19-mer interaction with PS-containing SUVs in 5P7.4.
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minus. This interaction appears to be similar for
both cis/trans peptide isomers, as indicated by com-
parable 1H linewidth broadenings and chemical shift
di¡erences of both tryptophan cis/trans populations.
Interresidue 1H nOe crosspeaks of tryptophan with
adjacent threonine and leucine sidechains indicate a
compact structure in this region. The tryptophan
sidechain penetrates the bilayer, as shown by NMR
chemical shift data, appearance of nOes with lipid
resonances, and changes to tryptophan £uorescence
emission. NOes between the tryptophan aromatic
ring and lipid headgroup resonances indicate that it
does not penetrate the bilayer deeply and does not
enter the acyl chain region appreciably. The ionic
and hydrophobic interactions near the 19-mer amino
terminus/tryptophan region therefore serve as a teth-
er of the peptide to SUV surface.
Closer to the carboxy terminus, the NMR data
reveal that the tyrosine resonances in the trans-pep-
tide isomer experience no apparent chemical shift
di¡erences nor selective linewidth broadening upon
addition of PC:PS SUVs. Thus, direct interaction of
this region with the bilayer is minimal, and its local
structure is not constrained in any preferred confor-
mation. The cis-peptide tyrosine resonances, how-
ever, experience slight up¢eld chemical shifts upon
addition of PC:PS SUVs; therefore, the cis-peptide
tyrosine residues experience small changes in elec-
tronic environment upon interaction with the bilayer.
Since the chemical shift di¡erences are small and no
interresidue or lipid nOe crosspeaks are evident, the
tyrosine interaction in this conformation is less sig-
ni¢cant than the tryptophan interaction.
Although the interaction of 19-mer with SUVs is
dependent upon the presence of a net negative charge
on the surface of the SUV, lipid packing and mobil-
ity as modi¢ed by SUV composition appear to mod-
ulate the interaction as well. SUVs composed entirely
of unsaturated acyl chain lipids (DOPC:DOPS) as-
sociate more strongly with 19-mer than do saturated
vesicles. As indicated by enhanced chemical shift dif-
ferences, tryptophan insertion appears to be more
extensive, possibly as a result of the greater £uidity
of the SUV bilayer. The e¡ects of lipid £uidity and
packing are most evident in the di¡erential interac-
tions of the peptide with DMPC:DMPS (1:1) and
DMPS SUVs. At the same PS concentration, the
mixed lipid vesicles show greater evidence of peptide
association than do pure PS vesicles (Fig. 5b,c and
Fig. 7). DMPS SUVs are less £uid than
DMPC:DMPS (1:1) SUVs at 37‡C, and, again, pep-
tide interaction and insertion appear to be enhanced
by more £uid bilayer phases.
In summary, in these model studies, the VSV 19-
mer shows signi¢cant membrane association that is
modulated both by speci¢c ionic and hydrophobic
factors along the length of the peptide and by the
speci¢c characteristics of the target membrane. One
plausible hypothesis for the role of this sequence in
the intact G protein is that of a fusion peptide-like
sequence that is revealed to target membranes during
pH-dependent G protein conformational changes
that occur during fusion. This sequence is atypical
of classic fusion peptides in that it is not entirely
composed of hydrophobic residues; yet it does con-
tain only hydrophobic and uncharged residues. The
low-pH dependence of G protein mediated viral fu-
sion most likely resides in a portion of the molecule
that is not contained in this 19 amino acid sequence
since only the carboxy terminus of the free peptide
would be susceptible to protonation at low pH. This
carboxy terminus is not pertinent to the sequence in
the intact protein. Thus, it is not expected that the
peptide, which lacks both acidic and basic residues,
would interact di¡erentially with model membranes
at pH values lower than 7.4. Furthermore, it is di⁄-
cult to study the e¡ects of low pH on the interaction
of the free 19-mer with phosphatidylserine-contain-
ing model membranes; in the absence of 19-mer, the
vesicles undergo aggregation and fusion as a result of
protonation of the phosphatidylserine headgroup.
Although the actual role of this epitope in the fusion
of G protein with target membranes in vitro and in
vivo remains to be determined, these model studies
have revealed evidence that its interaction with phos-
pholipids may have a direct involvement with the
infectivity of the virus.
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